The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.

Quantitative real-time polymerase chain reaction (qRT-PCR) is state of the art in molecular monitoring of minimal residual disease in chronic myeloid leukemia (CML). In this context, maintenance of assay fidelity and detection of technical inaccuracy are crucial. Beside multiple common negative cont...

Full description

Bibliographic Details
Main Authors: Birgit Spiess, Nicole Naumann, Norbert Galuschek, Sébastien Rinaldetti, Ute Kossak-Roth, Irina Tarnopolscaia, Elena Felde, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saußele, Wolfgang Seifarth
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5916859?pdf=render
id doaj-f98d248d87bb4c9e977372e56985b731
record_format Article
spelling doaj-f98d248d87bb4c9e977372e56985b7312020-11-25T02:19:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01134e019632610.1371/journal.pone.0196326The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.Birgit SpiessNicole NaumannNorbert GaluschekSébastien RinaldettiUte Kossak-RothIrina TarnopolscaiaElena FeldeAlice FabariusWolf-Karsten HofmannSusanne SaußeleWolfgang SeifarthQuantitative real-time polymerase chain reaction (qRT-PCR) is state of the art in molecular monitoring of minimal residual disease in chronic myeloid leukemia (CML). In this context, maintenance of assay fidelity and detection of technical inaccuracy are crucial. Beside multiple common negative controls for the clinical sample preparations, quality control charts (QCC) are a common validation tool to sustain high process quality by continuously recording of qRT-PCR control parameters. Here, we report on establishment and benefit of QCC in qRT-PCR-based CML diagnostics. The absolute quantification of BCR-ABL1 fusion transcripts in patient samples is based on coamplification of a serially diluted reference plasmid (pME-2). For QCC establishment the measured Ct values of each pME-2 standard dilution (4-400,000) of a test set resembling 21 sequential qRT-PCR experiments were recorded and statistically evaluated. Test set data were used for determination of warning limits (mean +/- 2-fold standard deviation) and control (intervention) limits (mean +/- 3-fold standard deviation) to allow rapid detection of defined out-of-control situations which may require intervention. We have retrospectively analyzed QCC data of 282 sequential qRT-PCR experiments (564 reactions). Data evaluation using QCCs revealed three out-of-control situations that required intervention like experiment repeats, renewal of pME-2 standards, replacement of reagents or personnel re-training. In conclusion, with minimal more effort and hands-on time QCC rank among the best tools to grant high quality and reproducibility in CML routine molecular diagnosis.http://europepmc.org/articles/PMC5916859?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Birgit Spiess
Nicole Naumann
Norbert Galuschek
Sébastien Rinaldetti
Ute Kossak-Roth
Irina Tarnopolscaia
Elena Felde
Alice Fabarius
Wolf-Karsten Hofmann
Susanne Saußele
Wolfgang Seifarth
spellingShingle Birgit Spiess
Nicole Naumann
Norbert Galuschek
Sébastien Rinaldetti
Ute Kossak-Roth
Irina Tarnopolscaia
Elena Felde
Alice Fabarius
Wolf-Karsten Hofmann
Susanne Saußele
Wolfgang Seifarth
The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
PLoS ONE
author_facet Birgit Spiess
Nicole Naumann
Norbert Galuschek
Sébastien Rinaldetti
Ute Kossak-Roth
Irina Tarnopolscaia
Elena Felde
Alice Fabarius
Wolf-Karsten Hofmann
Susanne Saußele
Wolfgang Seifarth
author_sort Birgit Spiess
title The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
title_short The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
title_full The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
title_fullStr The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
title_full_unstemmed The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
title_sort benefit of quality control charts (qcc) for routine quantitative bcr-abl1 monitoring in chronic myeloid leukemia.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description Quantitative real-time polymerase chain reaction (qRT-PCR) is state of the art in molecular monitoring of minimal residual disease in chronic myeloid leukemia (CML). In this context, maintenance of assay fidelity and detection of technical inaccuracy are crucial. Beside multiple common negative controls for the clinical sample preparations, quality control charts (QCC) are a common validation tool to sustain high process quality by continuously recording of qRT-PCR control parameters. Here, we report on establishment and benefit of QCC in qRT-PCR-based CML diagnostics. The absolute quantification of BCR-ABL1 fusion transcripts in patient samples is based on coamplification of a serially diluted reference plasmid (pME-2). For QCC establishment the measured Ct values of each pME-2 standard dilution (4-400,000) of a test set resembling 21 sequential qRT-PCR experiments were recorded and statistically evaluated. Test set data were used for determination of warning limits (mean +/- 2-fold standard deviation) and control (intervention) limits (mean +/- 3-fold standard deviation) to allow rapid detection of defined out-of-control situations which may require intervention. We have retrospectively analyzed QCC data of 282 sequential qRT-PCR experiments (564 reactions). Data evaluation using QCCs revealed three out-of-control situations that required intervention like experiment repeats, renewal of pME-2 standards, replacement of reagents or personnel re-training. In conclusion, with minimal more effort and hands-on time QCC rank among the best tools to grant high quality and reproducibility in CML routine molecular diagnosis.
url http://europepmc.org/articles/PMC5916859?pdf=render
work_keys_str_mv AT birgitspiess thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT nicolenaumann thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT norbertgaluschek thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT sebastienrinaldetti thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT utekossakroth thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT irinatarnopolscaia thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT elenafelde thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT alicefabarius thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT wolfkarstenhofmann thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT susannesaußele thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT wolfgangseifarth thebenefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT birgitspiess benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT nicolenaumann benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT norbertgaluschek benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT sebastienrinaldetti benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT utekossakroth benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT irinatarnopolscaia benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT elenafelde benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT alicefabarius benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT wolfkarstenhofmann benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT susannesaußele benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
AT wolfgangseifarth benefitofqualitycontrolchartsqccforroutinequantitativebcrabl1monitoringinchronicmyeloidleukemia
_version_ 1724874279441399808